Erlotinib Completed Phase 1 Trials for Advanced Pancreatic Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01010945Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer